To examine the longitudinal changes in adiposity and related risk variables of Syndrome X from childhood to young adulthood with respect to early onset of menarche. DESIGN: Community-based longitudinal cohort of female subject (65% white, 35% blacks subjects) who participated in two or more surveys from childhood to young adulthood and had reported their menarcheal age (o12 y, n ¼ 437 vs Z12 y, n ¼ 1042). RESULTS: In childhood (5-11 y), adolescence (12-18 y), and young adulthood (19-37 y), females with early menarche displayed significantly higher body mass index (BMI) and triceps skinfold thickness; higher stature in childhood and adolescence; higher fasting insulin and homeostasis model assessment index of insulin resistance (HOMA-IR) in childhood and adulthood; and higher fasting glucose in adulthood. Blood pressure and lipoprotein variables showed no early menarche-related differences. Longitudinal rates of change in BMI (P ¼ 0.002), triceps skinfold thickness (P ¼ 0.05), insulin (P ¼ 0.09), and HOMA-IR (P ¼ 0.05) were positive and faster among female subjects with early menarche; fasting glucose decreased slowly in this group (P ¼ 0.006). In a multivariate analysis, body fatness and insulin related independently to early menarche (Po0.001). This association was stronger in white subjects (P ¼ 0.0008). In adulthood, the prevalence of clustering of three to four risk factors of syndrome X (highest quartile of: (1) BMI, (2) fasting insulin, (3) systolic or mean arterial pressure, and (4) total cholesterol to HDL cholesterol or triglycerides to HDL cholesterol ratio specific for age, race, and study year) was higher among those with early menarche (10.7 vs 6.2%, P ¼ 0.002). The odds for developing such clustering in adulthood among those with early menarche was 1.54 (95% CI ¼ 1.14-2.07), regardless of race. CONCLUSION: Early menarche is characterized by excess body fatness and insulin beginning in early childhood and higher prevalence of clustering of adverse levels of risk variables of metabolic Syndrome X in young adulthood.
Introduction
Across the US, girls, especially black girls, are developing menarche at relatively younger age. 1, 2 Early menarche, an indicator of rapid biological maturation, is invariably associated with increased body fatness, [2] [3] [4] [5] [6] [7] [8] although there seems to be no threshold level of fatness required for the onset of menarche, 9 as previously envisioned. 10 Further, a link between body fatness and the hormonal changes that lead to the onset of menarche has been implicated. [11] [12] [13] [14] [15] [16] However, the temporal direction of this relationship remains uncertain. Nonetheless, in view of the secular trend toward increasing obesity occurring in the pediatric population of the US, 17, 18 it is important to examine the consequences of excess body fatness related to early menarche at the population level. That obesity is a risk factor for coronary heart disease and type II diabetes is now well recognized. 19 In part, this association is mediated through the development of insulin resistance/hyperinsulinemia and the attendant conditions of dyslipidemia and hypertension. Constellation of these disorders, which occur commonly in children and adults alike, [20] [21] [22] [23] [24] [25] has been termed Syndrome X, insulin resistance syndrome or metabolic syndrome. [26] [27] [28] Although fat mass and fat pattern change adversely with growth and maturation, 16 and maturation timing relates inversely to female obesity in young adulthood, 29 information is lacking on the timing and course of development of risk variables underlying the Syndrome X from childhood to young adulthood among those who experienced early menarche.
Observations from the Bogalusa Heart Study, a long-term community-based study of cardiovascular risk factors since childhood, 30 have shown that a secular trend of earlier onset of menarche paralleled an upward secular trend in obesity in the study population, with obesity measures having significant inverse relationship to the age of menarche. 2 The present study examines the longitudinal changes in adiposity and related risk variables of Syndrome X from childhood to young adulthood with respect to early onset of menarche.
Methods

Population
The Bogalusa Heart Study is being conducted in a semirural, biracial (65% white, 35% black people) community of Bogalusa, Louisiana. Six cross-sectional surveys of children aged 5-17 y were conducted between 1973 and 1988. In addition, five cross-sectional surveys of young adults aged 18-37 y who have been previously examined as children and were accessible were conducted between 1979 and 1996. This panel design, based on repeated cross-sectional examinations, resulted in serial observations from childhood to young adulthood required for the longitudinal analysis. However, since this is not a prospective study by design, not every participant has been examined in all surveys. The participation rate was approximately 80% for the children and 60% for the young adult cohort. The study cohort (n ¼ 1479) was selected from 1962 young adult females who participated in two or more surveys from childhood to adulthood and provided information on menarcheal age during examination in childhood. The study cohort consisted of 65% white and 35% black subjects, reflecting the black-white distribution of the community. The distribution of the cohort by age at the last survey and number of screenings between childhood and adulthood are given in Table 1 . In all, 82% of subjects were screened four times or more and only 5.7% were screened twice since childhood.
General examination
Identical protocols were used by trained examiners across all surveys. 31 Subjects were instructed to fast for 12 h prior to screening, and compliance was determined by interview on the morning of examination. Anthropometrics and blood pressure measurements were made in replicate and mean values were used in all analyses. Height and weight were measured twice to 70.1 cm and 70.1 kg, respectively. As a measure of overall adiposity, the body mass index (BMI ¼ weight in kilograms divided by the square of height in meters) was used. Triceps skinfold thickness was measured in triplicates. Systolic and diastolic (fourth phase for children and fifth phase for adults) blood pressure levels were measured in six replicates by two randomly assigned and trained observers on the right arm of participants in a relaxed, sitting position. Mean arterial pressure was calculated as diastolic blood pressure plus onethird of pulse pressure. Plasma immunoreactive insulin levels were measured by a commercial radioimmunoassay kit (Phadebas; Pharmacia Diagnostics, Piscataway, NJ, USA). The high crossreactivity (41%) of the assay with proinsulin should not affect the insulin measurements because proinsulin is secreted in very low amounts relative to insulin in individuals without diabetes. From 1978 to 1991, plasma glucose was measured by a glucose oxidase method using a Beckman glucose analyzer (Beckman Instruments, Fullerton, CA, USA). Since then it has been measured enzymatically as part of a multichemistry profile. The intraclass correlation coefficient between the blind duplicate values ranged from 0.94 to 0.98 for insulin and 0.86 to 0.98 for glucose. An index of insulin resistance was calculated according to the homeostasis assessment model formula: 34 HOMA-IR ¼ fasting insulin Early menarche and risk of metabolic Syndrome X in youth MG Frontini et al (mU/ml) Â fasting glucose (mmol/l)/22.5. This model is considered useful to assess insulin resistance in epidemiologic studies. 35 
Laboratory analysis
Menstrual history
As previously described, 2 information on menarcheal age was obtained through interview by a nurse. Girls in the third grade and above were first asked whether they had ever had a menstrual period (the term menstrual period was explained, if needed). Postmenarcheal girls were asked to identify the month and year of their first period. As most girls provided the year but not the month of menarche, it was assumed in the analysis that menarche occurred at the midpoint of the given year. Regarding the reliability of self-reported age at menarche, our earlier study showed that reported menarcheal age at the first and the second longitudinal surveys differed by 1 y or less among 84% of the girls, and this estimate was similar among white girls (85%) and black girls (83%). 36 The first reported menarcheal age was used.
Statistical analyses
For all comparisons, participants were divided into two groups based on their age of menarche: o12 and Z12 y. Mean levels of risk variables by age groups 5-7, 8-11, 12-18, and 19-37 y corresponding to preadolescence, adolescence, and adulthood periods were compared between groups with and without early menarche. Single measurements per subject were used to calculate mean levels of risk variables within age groups. Age-specific mean levels of risk variables were compared between menarcheal groups by general linear models adjusting for age, race, and survey year. The assessment of longitudinal rates of change in risk variables was made by using the generalized estimation equation method (GEE) with age as predictor, adjusting for race. The percentile (75th) used as the cut-point to define adverse level was age-, race-and study year specific. The four metabolic and hemodynamic variables considered as components of Syndrome X were the highest quartile of (1) BMI, (2) fasting insulin, (3) systolic or mean arterial blood pressure, and (4) total cholesterol to HDL cholesterol ratio or triglycerides to HDL cholesterol ratio. Clustering was defined as coexistence of two or three to four of these variables. The w 2 test was used to assess the difference in the proportion of subjects with clustered adverse levels of risk variables and a logistic regression model was used to obtain the odds ratio of developing clustering in adulthood based on menarcheal age. The longitudinal association of early menarche with risk variables was assessed by multivariate analyses (GEE) using logit as link function and binomial distribution of the outcome. Two models were set: model 1 included BMI, HOMA-IR, LDL cholesterol, HDL cholesterol, and triglyceride; model 2 included the same set of variables except that BMI was replaced by triceps skinfold thickness. A backward stepwise method was used.
Results
Mean values of BMI, triceps skinfold thickness, height, glucose, insulin, and HOMA index of insulin resistance in childhood (5-7 and 8-11 y), adolescence (12-18 y), and during adulthood (19-37 y) are shown in Figures 1 and 2 by menarcheal age. Comparisons were made after adjusting for age. Since the mean values in each age group were similar in both the races, data in black and white female subjects were combined to examine the differences between menarcheal age groups. Menarcheal age <12y ≥12y Figure 1 Mean levels of obesity measures and height from childhood to young adulthood by menarcheal Age.
Early menarche and risk of metabolic Syndrome X in youth MG Frontini et al significantly higher in female subjects with early menarche. Female subjects with early menarche were relatively taller in childhood and adolescence years. However, adulthood stature was similar between the menarcheal age groups. Higher mean levels of insulin and HOMA-IR were observed in all age groups of female subjects with early menarche. However, the differences were significant only among 5-7 and 19-37 y age group. Mean levels of fasting glucose among those with early menarche were significantly higher when they reached adulthood age of 19-37 y, although levels tended to be higher among 5-7 and 12-18 y age groups. The mean levels of serum lipid and lipoprotein variables as well as blood pressure variables in childhood, adolescence, and adulthood remained similar between the early menarche and control groups (data not shown).
Longitudinal rate of change in risk variables are presented in Table 2 by menarcheal age. The rates of increase in BMI, triceps skinfold thickness, and HOMA-IR were significantly higher among those with early menarche. The rate of change in insulin was positive among early menarcheal age group and negative among controls. However, the difference between the two groups was only marginal. Further, the rate of decrease in glucose was significantly lower among those who developed early menarche. Longitudinal rate of changes in height, lipoprotein variable, and blood pressure variables did not show differences between the groups.
The independent correlates of early menarche were determined in separate multivariate models because of the strong correlation between obesity measures. BMI showed a significant and independent association with early menarche. A significant interaction between BMI and race indicated that the strength of the association was higher among white female subjects. Triceps skinfold thickness and insulin showed independent associations with early menarche. The strength of the association between triceps skinfold and early menarche was again higher among white female subjects.
The effect of early menarche on the prevalence of adverse levels (values above the 75th percentile specific for study period, age, race, and sex) of different number (0,1, 2, and 3 or 4) of criterion risk variables of Syndrome X in adulthood is shown in Figure 3 . Overall, the prevalence of multiple risk factors in adulthood was higher among those who developed early menarche (Po0.01). In particular, the prevalence of clustering of three or four risk factors was 1.8-fold higher among those with early menarche compared to those with regular menarche (10.7 vs 6.0%, P ¼ 0.002). Further, among those with early menarche, the odds of developing clustering of three or four risk factors in adulthood was 1.54 (95% confidence interval (CI) ¼ 1.14-2.07). Menarcheal age <12 ≥12 Figure 2 Mean levels of glucose, Insulin, and HOMA-IR from childhood to young adulthood by menarcheal age. Early menarche and risk of metabolic Syndrome X in youth MG Frontini et al
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Discussion
The present study shows that female subjects who had early menarche displayed excess body fatness, assessed by BMI and triceps skinfold thickness, and higher levels of fasting insulin and HOMA-IR as early as 5-7 y of age, and higher levels of fasting glucose in young adulthood. In terms of longitudinal rate of change from childhood to adulthood, these variables changed adversely from childhood to young adulthood in this group. Further, early menarche was associated with enhanced clustering of adverse levels of risk variables of Syndrome X. These observations are noteworthy in that, to our knowledge, no comparable longitudinal data pertaining to early menarche and risk variables of Syndrome X measured concurrently are available at a community level in the US general population.
The occurrence of excess body fatness as early as 5-7 y of age and its accelerated increase through adulthood among the study cohort who experienced early menarche is consistent with the known inverse association between menarcheal age and childhood adiposity. [2] [3] [4] [5] [6] [7] [8] 10 However, it is not clear whether it is in accordance with the concept that a threshold level of fatness is required for triggering early menarche. 10 Nonetheless, the accumulation of body fat already seen at 5-7 y of age among the study cohort with early menarche suggested that body fatness, concurrent neuroendocrine hormonal changes, and early onset of menarche are somehow linked. Although a number of putative mechanisms that underline this relationship have been proposed, 11-15 the current observational study was not designed to examine mechanisms. In this study, the association between early menarche and the degree of body fatness was stronger in white vs black subjects. A similar black-white divergence in the strength of relationship between excess body fatness and early menarche has been found previously, 7 although the reason for this is not clear. Ethnic-based genetic factors are considered to be involved in this relationship because Hispanic girls despite their higher adiposity than both white and black girls 37 do not develop menarche earlier than white or black subjects. 16, 38 Further, it has been found that the ethnic differences in menarcheal age and Tanner stages of puberty remained even after adjusting for current adiposity and social and economic factors. 39 As in previous studies, 36, [40] [41] [42] [43] the study cohort with early menarche was taller even before the onset of menarche and continued to be so until the postmenarcheal age of 18 y. Age at peak height velocity, an indication of maximal bone growth and skeletal maturation, is known to precede the onset of menarche, probably reflecting the prepubertal stimulation by growth hormone. 17 However, the terminal height at adulthood in the study cohort was similar between the menarcheal age groups. The current study cohort with a history of early menarche also displayed higher fasting insulin levels and HOMA-IR, in early childhood period (5-7 y of age). Further, while rates of change of these variables from childhood to adulthood were positive and faster, fasting glucose levels decreased at a slower rate in this group. As a result, levels of these three variables were significantly higher in this group. Studies have shown inter-relationships between hyperinsulinemia/insulin resistance, premature adrenarche, and rate of pubertal development. [44] [45] [46] Premature pubarche secondary to premature adrenarche was found to be associated with hyperinsulinemia/insulin resistance and dyslipidemia, but not with excess body fatness and high blood pressure in girls aged 6-18 y. 47 It should be noted that onset of puberty and menarche are not parallel pubertal events 11 Early menarche and risk of metabolic Syndrome X in youth MG Frontini et al body fatness and insulin beginning in early childhood and the enhanced clustering of adverse levels of risk variables of Syndrome X in young adulthood. Obesity is commonly linked to insulin resistance/hyperinsulinemia, which in turn is thought to mediate other disorders of Syndrome X such as dyslipidemia and hypertension. 23, [26] [27] [28] Unexpectedly, levels of lipoproteins and blood pressure variables were similar between the menarcheal age groups from childhood to young adulthood in the study cohort. It should be noted, however, that those who developed menarche at or after 12 y of age, although relatively less fatter compared with those who experienced early menarche, may not necessarily be characterized as lean. Therefore, it is likely that any subtle differences in lipoproteins and blood pressure variables between these two groups may not be readily apparent. Despite this, the odds for developing clustering of three or four risk factors that included adverse levels of blood pressure and lipoproteins in adulthood was 1.54 times higher among those with early menarche compared with the rest of the cohort. This study has certain limitations. The menarcheal age was based on self-report. Reliability of self-reported age at menarche, especially over short periods, is reasonably good. 48, 49 We obtained information on menarcheal age only during childhood and adolescence periods. Our earlier analysis of girls who were examined two times after menarche showed that the reported menarcheal age differed by 1 y or less among 85% of white girls and 83% of black girls. 36 It should be noted that random misclassification of self-reported history would underestimate the true differences between groups. This study also lacks serial measurements of glucose tolerance and in vivo insulin action and secretion used in clinical and etiological studies. Instead, we used the glucose homeostasis measures that are relatively easily measured and applicable at population levels. In summary, early menarche is characterized by excess body fatness and insulin beginning in early childhood, and higher prevalence of clustering of adverse levels of risk variables of metabolic Syndrome X in young adulthood. Besides genetic variation and hormonal changes, modifiable factors like overnutrition in combination with sedentary lifestyle are considered as mediators in the biologic maturation. 17, 50 Irrespective of the putative causes, the current findings may have implications for public health.
